Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 7, 2011, Pages 732-740

  Behrens, Maria I ^a,b,c   Silva, Monica ^c   Schmied, Astrid ^d   Salech, Felipe ^d   Manzur, Hachi ^d   Rebolledo, Rolando ^d   Bull, Ricardo ^d   Torres, Vicente ^c,d   Henriquez, Mauricio ^c,d   Quest, Andrew F G ^c,d  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

Aging; Apoptosis; Human lymphocytes; Necrosis; PARP 1

Indexed keywords

HYDROGEN PEROXIDE; OXIDIZING AGENT;

ADULT; AGED; AGING; APOPTOSIS; ARTICLE; CELL AGING; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NECROSIS; OXIDATIVE STRESS; PATHOLOGY; REFERENCE VALUE; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; AGING; APOPTOSIS; CELL AGING; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; HYDROGEN PEROXIDE; LYMPHOCYTES; MIDDLE AGED; NECROSIS; OXIDANTS; OXIDATIVE STRESS; REFERENCE VALUES; YOUNG ADULT;

EID: 80051518362     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr039     Document Type: Article

References (47)

1. Warner HR, Sierra F. Nuclear architecture and disease. J Gerontol A Biol Sci Med Sci. 2006;61(5):461-462. (Pubitemid 43794703)
2. Burtner CR, Kennedy BK. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol. 2010;11(8):567-578.
3. Pollack M, Leeuwenburgh C. Apoptosis and aging: role of the mitochondria. J Gerontol A Biol Sci Med Sci. 2001;56(11):B475-B482. (Pubitemid 33043471)
4. Joaquin AM, Gollapudi S. Functional decline in aging and disease: a role for apoptosis. J Am Geriatr Soc. 2001;49(9):1234-1240. (Pubitemid 32900153)
5. Zhang JH, Zhang Y, Herman B. Caspases, apoptosis and aging. Ageing Res Rev. 2003;2(4):357-366. (Pubitemid 37159398)
6. Henriquez M, Armisen R, Stutzin A, Quest AF. Cell death by necrosis, a regulated way to go. Curr Mol Med. 2008;8(3):187-206. (Pubitemid 351982538)
7. Joza N, Pospisilik JA, Hangen E, et al. AIF: not just an apoptosis-inducing factor. Ann N Y Acad Sci. 2009;1171:2-11.
8. Galluzzi L, Aaronson SA, Abrams J, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009;16(8):1093-1107.
9. Galluzzi L, Maiuri MC, Vitale I, et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007;14(7):1237-1243. (Pubitemid 46969863)
10. McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett. 1998;99(3):157-168. (Pubitemid 28529119)
11. Lee MW, Kim WJ, Beardsley DI, Brown KD. N-methyl-N'-nitro- N-nitrosoguanidine activates multiple cell death mechanisms in human fibroblasts. DNA Cell Biol. 2007;26(9):683-694.
12. Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325(5938):332-336.
13. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett. 1998;102-103:139-142. (Pubitemid 29021213)
14. Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY, Rakic P. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J Neurosci. 2001;21(13):4752-4760. (Pubitemid 32565633)
15. Zeiss CJ. The apoptosis-necrosis continuum: insights from genetically altered mice. Vet Pathol. 2003;40(5):481-495. (Pubitemid 38393553)
16. Hassa PO. The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survival. Front Biosci. 2009;14:72-111.
17. Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev. 2006;20(1):1-15. (Pubitemid 43042662)
18. Pollack M, Phaneuf S, Dirks A, Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci. 2002;959:93-107. (Pubitemid 34457555)
19. Hetz CA, Hunn M, Rojas P, Torres V, Leyton L, Quest AF. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase. J Cell Sci. 2002;115(Pt 23):4671-4683.
20. Donati A, Recchia G, Cavallini G, Bergamini E. Effect of aging and anti-aging caloric restriction on the endocrine regulation of rat liver autophagy. J Gerontol A Biol Sci Med Sci. 2008;63(6):550-555.
21. Dunkle A, He YW. Apoptosis and autophagy in the regulation of T lymphocyte function. Immunol Res. In press.
22. Szumiel I. Autophagy, reactive oxygen species and the fate of mammalian cells. Free Radic Res. 2011;45(3):253-265.
23. Fitzpatrick AL, Kronmal RA, Kimura M, et al. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. In press.
24. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol. 1998;160(4):1627-1637. (Pubitemid 28106447)
25. Villena J, Henriquez M, Torres V, et al. Ceramide-induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells. Free Radic Biol Med. 2008;44(6):1146-1160.
26. Oktyabrsky ON, Smirnova GV. Redox regulation of cellular functions. Biochemistry (Mosc). 2007;72(2):132-145. (Pubitemid 46347478)
27. Thorne KJ, Svvennsen RJ, Franks D. Role of hydrogen peroxide in the cytotoxic reaction of T lymphocytes. Clin Exp Immunol. 1980;39(2):486-495. (Pubitemid 10128444)
28. Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol. 2008;9(5):378-390. (Pubitemid 351574200)
29. Boujrad H, Gubkina O, Robert N, Krantic S, Susin SA. AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle. 2007;6(21):2612-2619. (Pubitemid 350224042)
30. Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene. 2004;23(16):2785-2796. (Pubitemid 38638842)
31. Susin SA, Daugas E, Ravagnan L, et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med. 2000;192(4):571-580.
32. Wang Y, Kim NS, Li X, et al. Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos). J Neurochem. 2009;110(2):687-696.
33. Baritaud M, Boujrad H, Lorenzo HK, Krantic S, Susin SA. Histone H2AX: the missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle. 2010;9(16):3166-3173.
34. Artus C, Boujrad H, Bouharrour A, et al. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J. 2010;29(9):1585-1599.
35. Burkle A. DNA repair and PARP in aging. Free Radic Res. 2006;40(12):1295-1302. (Pubitemid 44698279)
36. Kim MY, Zhang T, Kraus WL. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev. 2005;19(17):1951-1967.
37. Piskunova TS, Yurova MN, Ovsyannikov AI, et al. Deficiency in poly(ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice. Curr Gerontol Geriatr Res. 2008;754190: 1-11.
38. Grube K, Burkle A. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc Natl Acad Sci U S A. 1992;89(24):11759-11763. (Pubitemid 23004723)
39. Chevanne M, Calia C, Zampieri M, et al. Oxidative DNA damage repair and parp 1 and parp 2 expression in Epstein-Barr virus-immortalized B lymphocyte cells from young subjects, old subjects, and centenarians. Rejuvenation Res. 2007;10(2):191-204.
40. Malanga M, Romano M, Ferone A, et al. Misregulation of poly (ADP-ribose) polymerase-1 activity and cell type-specific loss of poly(ADP-ribose) synthesis in the cerebellum of aged rats. J Neurochem. 2005;93(4):1000-1009. (Pubitemid 40695759)
41. Mangerich A, Herbach N, Hanf B, et al. Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1. Mech Ageing Dev. 2010;131(6):389-404.
42. Sodhi RK, Singh N, Jaggi AS. Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascul Pharmacol. 2010;53(3-4):77-87.
43. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010;10(4):293-301.
44. Mangerich A, Burkle A. How to kill tumor cells with inhibitors of poly(ADP-ribosyl)ation. Int J Cancer. 2011;128(2):251-265.
45. Aggarwal S, Gupta S. Increased activity of caspase 3 and caspase 8 in anti-Fas-induced apoptosis in lymphocytes from ageing humans. Clin Exp Immunol. 1999;117(2):285-290. (Pubitemid 29343599)
46. Agrawal A, Agrawal S, Gupta S. Dendritic cells in human aging. Exp Gerontol. 2007;42(5):421-426. (Pubitemid 46561174)
47. Schindowski K, Leutner S, Muller WE, Eckert A. Age-related changes of apoptotic cell death in human lymphocytes. Neurobiol Aging. 2000;21(5):661-670.